INTRODUCTION
Neutrophils (PMNs) play a central role in host defence, and production of the lipid mediators leukotriene B % (LTB % ) and platelet-activating factor (PAF) is an important aspect of PMN function during normal inflammation. Increased PMN activity has also been associated with both acute and chronic inflammatory states such as sepsis syndrome, adult respiratory distress syndrome, rheumatoid arthritis and asthma, with enhanced production of both PAF and LTB % being implicated in the pathogenesis of these disorders (reviewed in [1, 2] ). The initial and rate-limiting enzyme responsible for both LTB % and PAF formation in PMNs is believed to be an sn-2-acylhydrolase, phospholipase A # (PLA # ) [3, 4] . PMNs contain at least two types of Ca# + -dependent PLA # [5] , a 14 kDa PLA # termed ' secretory ' PLA # (sPLA # ) and an 85 kDa enzyme localized in the cytosol of resting cells called ' cytosolic ' PLA # (cPLA # ). Although substantial progress has been made in understanding the role of these enzymes in the generation of LTB % and PAF in PMNs, the mechanism that links cell stimulation to actual activation of one or both types of PLA # has remained elusive. Phosphatidic acid (PA), produced by phospholipase D (PLD) activation, and diglycerides (DGs) subsequently formed via cleavage of PA by phosphatidate phosphohydrolase, have been proposed to act as intracellular second messengers to link cell [5,6,8,9,11,12,14,15- 3 H]arachidonic acid ; 5-HETE, 5-hydroxyeicosatetraenoic acid ; [ 3 H]lyso-PAF, 1-O-[9h,10h-3 H]hexadecyl-2-lyso-glycerophosphatidylcholine; HSA, human serum albumin ; LTB 4 , leukotriene B 4 ; MAP kinase, mitogen-activated protein kinase ; PMNs, polymorphonuclear leucocytes (neutrophils) ; PA, phosphatidic acid ; PAF, platelet-activating factor ; Pet, phosphatidylethanol ; PKC, protein kinase C ; PLA 2 , phospholipase A 2 ; PLC, phospholipase C ; PLD, phospholipase D ; PMA, phorbol 12-myristate 13-acetate ; sPLA 2 , secretory PLA 2 ; TNFα, tumour necrosis factor α.
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Leu-Phe, AA release and metabolism and PAF formation increased in parallel with enhanced PA and DG formation, and inhibition of PA and DG production led to a decrease in both AA release and PAF accumulation. In α-toxin-permeabilized PMNs, AA release and PAF production result from the specific activation of cytosolic PLA # (cPLA # ). In this system, PA and DG formation were always present when cPLA # activation occurred ; blocking PA and DG production inhibited AA release and PAF accumulation. Adding either PA or DG back to permeabilized cells (with endogenous PA and DG formation blocked) led to a partial restoration of AA release and PAF formation ; a combination of PA and DGs reconstituted full cPLA # activity. These results strongly suggest that products of PLD participate in activating cPLA # in PMNs.
stimulation to cellular responses (reviewed in [6] ). PMNs contain PLD(s) that cleave both phosphatidylcholine and phosphatidylinositol in response to physiological stimuli [7] [8] [9] , and many of the same agonists that induce PLD activity also initiate PLA # activation in PMNs. The interrelationships between different pathways involved in phospholipid metabolism are not well understood ; in this study the potential role of the products of PLD activation in the induction of PLA # activation in PMNs were examined.
Studying mechanisms of phospholipase activation in intact cells has been difficult because cell stimulation leads to the activation of multiple pathways. The delineation of steps involved in a single path is complicated, and the determination of how different paths interact is nearly impossible. Cell-free or isolated enzyme systems have been used for most studies investigating requirements for enzyme activation ; however, these systems are not suitable for addressing signal transduction steps involved in enzyme activation or for assessing the interrelationship between enzyme systems. To overcome some of the problems inherent in both approaches, we have used PMNs permeabilized with Staphylococcus aureus α-toxin to study the interrelationship between PLD and PLA # activation. Permeabilized cell systems have been used to elucidate signal transduction mechanisms leading to enzyme activation in a number of cell types [10] [11] [12] . Many methods are available for cell permeabilization [13, 14] but the α-toxin of S. aureus has several advantages [12, 15] . α-Toxin monomers interact on the surface of cells to form 2-3 nm diameter pores in the plasma membrane. The pores prevent leakage of macromolecules from the cell but allow small molecules (less than 1000 Da) added extracellularly to move freely with very rapid penetration and equilibration into the cytosol [10] . α-Toxin monomers (larger than 28 kDa) are too large to pass through the pores, so only membranes facing the extracellular space are affected ; intracellular structures are not altered. This model allows cellular enzymes and proteins to be maintained in situ but allows potential regulators of enzyme activation to be selectively added. We have used this model to study the requirements for both PLD [11] and PLA #
[16] activity in PMNs and have shown selective activation of cPLA # in the absence of detectable sPLA # activity in the permeabilized cells ; further work has demonstrated that both PAF and LTB % production occur in this system [17] .
In this study the role of PLD-mediated PA and DG formation in the induction of PLA # activity was first investigated in intact PMNs primed with tumour necrosis factor α (TNFα) before stimulation with the chemotactic peptide N-formyl-Met-Leu-Phe (FMLP). The permeabilized PMN model was then used to demonstrate that : (1) PA and DG formation were always present when cPLA # activity was evident ; (2) blocking PA and DG formation led to a parallel reduction in arachidonic acid (AA) release and metabolism and PAF formation ; (3) adding either PA or DGs back to cells partly restored cPLA # activity ; (4) the addition of a combination of PA and DGs at physiologically relevant concentrations completely reconstituted cPLA # activity. These results strongly suggest that products of PLD activation participate in the induction of PLA # activity in human PMNs. 
EXPERIMENTAL Reagents

α-Toxin preparation
α-toxin was prepared as previously described [10] .
PMN isolation
PMN populations (more than 95 % PMNs) were prepared by layering heparinized venous blood from normal adult volunteers over Isolymph (Gallard-Schlesinger Chemical Manufacturing Corporation ; 3 ml of blood per ml of Isolymph) for red cell sedimentation. Collected cells were centrifuged through Isolymph to eliminate mononuclear cells ; contaminating erythrocytes were removed by hypotonic lysis. PMNs were resuspended in PBS supplemented with 0.1 % gelatin (Sigma) at 5i10( cells\ml.
Labelling of PMNs with 3 H
Isolated PMNs were prelabelled with [5, 6, 8, 9, 11, 12, 14 
Primed stimulation of PLA 2 and PLD in intact PMNs
PMNs (final concentration 5x10' cells\ml) were resuspended in PBS containing 1 mM Ca# + for assessment of PLA # and PLD activities. Cells were treated with 5 µg\ml cyto B for 5 min at 37 mC and primed with 100 i.u.\ml TNFα (or HSA containing buffer) for 30 min. Samples were then stimulated with 1 µM FMLP for an additional 5 min. Cellular lipids were obtained by vortex-mixing cells with chloroform\methanol (1 : 2, v\v) acidified with 0.15 ml of 9 % formic acid (3 ml\ml of cells) and extracting lipids as described below.
Cell permeabilization
Human PMNs were permeabilized with α-toxin in a ' cytoplasmic ' buffer consisting of 140 mM KCl, 1 mM MgCl, 1 mM MgATP# − , 10 mM glucose, 10 mM Hepes, 0.1 % gelatin and 1 mM EGTA, pH 7.4, for 15 min at 37 mC as previously described [10, 11] .
PLA 2 and PLD activation in permeabilized PMNs
For phospholipase assays, PMNs (final concentration 5i10' cells\ml) were permeabilized in cytoplasmic buffer supplemented with 100 µM acetyl-CoA. Cofactors and stimuli (no cyto B was used in permeabilized PMNs) were added 15 min after α-toxin, and reactions were halted by vortex-mixing cells with chloroform\methanol at the indicated times.
Lipid extraction
Lipids were extracted by a modification of the Bligh and Dyer technique [18] . After chloroform\methanol addition, samples were mixed with 5 µl of phosphatidylcholine (10 mg\ml), 2 ml of chloroform and 1 ml of water (per ml of the original cell solution) and vortex-mixed. After centrifugation, organic layers were retained, solvents were evaporated under nitrogen and samples resuspended in chloroform\methanol (9 : 1, v\v [19, 20] . PAF, PA, alkylacylglycerol and Pet formation were assessed in PMNs labelled with [$H]lyso-PAF. PAF isolation was performed on Silica Gel G plates in a solvent system of chloroform\methanol\acetic acid\ water (50 : 25 : 8 : 4, by vol.) [20, 21] . PA, Pet and alkylacylglycerol were isolated by TLC in the organic phase of a solvent system containing ethyl acetate\iso-octane\acetic acid\water (110 : 50 : 20 : 100, by vol.) on Silica Gel 60 TLC plates (Curtin Matheson Scientific, Florence, KY, U.S.A.) [9] . Fractions, based on the location of lipid standards, were scraped from the TLC plates and assayed by liquid-scintillation counting (Model LS 1801, Beckman Instruments).
Lipid preparation for fatty acid mass determination
AA mass was determined as previously described [16] by using octadeuterated AA and trideuterated stearic acid 
GLC-MS
Pentafluorobenzyl esters were analysed by negative-ion chemicalionization GLC-MS [22] . Carboxylate anions at m\z 303 and 311 for AA and octadeuterated AA respectively were monitored with a Hewlett-Packard mass spectrometer (HP 5989A) interfaced to a Hewlett-Packard series II gas chromatograph (HP 5890). Quantities of released AA were determined from a standard curve obtained with octadeuterated AA as the internal standard.
Determination of free Ca 2 + levels
Free Ca# + levels (1 µM or less) were determined by the fluorescence of fura 2 (free salt, 3 µM ; Molecular Probes, Eugene, OR, U.S.A.) in a fluorimeter (SLM 8000, SLM Instruments ; excitation wavelengths of 340 and 380 nm and emission wavelength of 510 nm).
Statistics and data presentation
Results were tested for statistical significance with Student's t test or analysis of variance followed by Tukey's procedure ; values of P 0.05 were considered statistically significant. Results from radiolabelled assays are displayed as the level of $H label found in specific lipid fractions as a percentage of total label recovered. 
RESULTS
TNFα priming of PLA 2 and PLD in human PMNs
Initial studies in this investigation focused on determining the relationship between PLA # and PLD activation in intact PMNs. In previous reports the ability of TNFα to prime PMNs for enhanced AA release and metabolism, PAF formation and PA production when cells were subsequently stimulated was characterized [9, 20] . Table 1 summarizes the results obtained when cells pretreated with cyto B were primed with 100 i.u.\ml TNFα for 30 min and then stimulated with 1 µM FMLP for 5 min. In the absence of priming (PMNs treated with buffer containing HSA, the carrier for TNFα), stimulation with FMLP induced modest increases in AA release (combination of $H found in the fatty acid, LTB % and 5-HETE fractions) and PAF formation. Priming with TNFα did not directly increase AA release and metabolism or PAF formation, but when primed cells were subsequently stimulated with FMLP, total free AA was twice the AA levels found in resting cells (HSA control) and PAF formation was more than tripled. Under the same conditions, PA formation in unprimed cells was significantly increased by FMLP stimulation (3.5-fold increase in PA levels). TNFα did not cause any increase in PA levels in the absence of stimulation but did enhance PA formation in PMNs stimulated with FMLP to more than a 5-fold increase over control values.
[$H]Lyso-PAF has an alkyl linkage in the sn-1 position, so an assessment of DG formation in [$H]lyso-PAF labelled PMNs monitors only alkylacylglycerol formation. In contrast, when PMNs are radiolabelled with [$H]AA for short periods, most AA is incorporated into the 2 position of the diacyl species of phosphatidylcholine and phosphatidylinositol [3, 19, 22] and DGs produced will be primarily of the diacylglycerol molecular species. Thus, to characterize DG formation fully during primed stimulation of PMNs, the production of both alkylacylglycerol and 3 H-]yso-PAF (PAF, PA and alkylacylglycerol formation) were pretreated with 5 µg/ml cyto B for 5 min at 37 mC. Cells were then primed with TNFα (or HSA) for 30 min before stimulation with FMLP or buffer. Reactions were halted after 5 min and lipids were extracted and analysed as described in the Materials and methods section. diacylglycerol was assessed. In unprimed PMNs, stimulation with FMLP caused the formation of very high levels of alkylacylglycerol (nearly a 10-fold increase) but only a modest increase in diacylglycerol formation. Priming with TNFα did not effect basal levels of either form of DG but enhanced the formation of both in cells subsequently stimulated with FMLP. These results demonstrate that both PA and DG formation were present when AA release and PAF formation occurred and that the enhanced PLA # activity seen during primed stimulation was paralleled by an increased formation of both PA and DGs.
Role of PLD in PA and DG formation in PMNs primed with TNFα and stimulated with FMLP
PA formation can occur directly through the activation of PLD or indirectly by the sequential actions of phospholipase C (PLC) and DG kinase. Primary alcohols compete with water in a transphosphatidylation reaction during PLD activation to produce Pet rather than PA [23] and can be used to differentiate between PLD-and PLC-mediated PA formation. To characterize which path was involved in the induction of PA formation in cells primed with TNFα before stimulation with FMLP, the effects of increasing concentrations of ethanol on PA ( Figure 1A ) and Pet ( Figure 1B ) formation were determined. In the absence of stimulation (PMNs treated with either HSA or TNFα), increasing ethanol concentrations from 0 % to 2.5 % (v\v) (a final concentration of 2.5 % ethanol did not alter cell viability as assessed by Trypan Blue exclusion) had little effect on PA or Pet levels. In cells stimulated with FMLP, with or without TNFα priming, a dose-dependent inhibition of PA formation occurred in response to increasing concentrations of ethanol ; a concomitant increase in Pet formation was observed, with maximum levels of Pet attained between 0.5 and 1 % ethanol. Above 1 % ethanol, Pet levels declined, suggesting enzyme inactivation. Thus PA formed in this system seemed to result primarily from the activation of PLD.
DG production in PMNs might occur through the direct hydrolysis of phospholipids by PLC or by the PLD-mediated formation of PA followed by phosphatidate phosphohydrolase action to form DGs. To assess which path was responsible for the DG production observed during primed stimulation, the effects of ethanol on the formation of both alkylacylglycerol ( Figure 1C ) and diacylglycerol ( Figure 1D ) was also assessed. Increasing ethanol concentrations again had little effect on DG levels in cells in the absence of stimulation. However, in cells treated with FMLP, with or without initial priming with TNFα, the addition of ethanol to the system led to a dose-dependent decrease in both alkylacylglycerol and diacylglycerol formation. This result demonstrated that PLD activity followed by phosphatidate phosphohydrolase-mediated cleavage of PA was responsible for the majority of DGs produced in PMNs stimulated with FMLP, with or without TNFα priming.
Effects of ethanol on PLA 2 activity in PMNs primed with TNFα and stimulated with FMLP
If PA and DGs participate in the signal transduction system that initiates PLA # activity in PMNs, then blocking their formation should affect AA release and metabolism and PAF accumulation. In Figure 2 the effects of ethanol on PLA # activation in PMNs primed with TNFα before stimulation with FMLP were determined. Increasing the ethanol concentration from 0 % to 2.5 % had little effect on AA (Figure 2A ) or PAF ( Figure 2B ) levels in cells treated with either HSA or TNFα in the absence of stimulation. In both unprimed and primed PMNs stimulated with FMLP, a dose-dependent inhibition in AA release and metabolism and PAF formation was observed : AA release was diminished to near-basal levels by 1 % ethanol, and PAF production completely abolished at 0.5 % ethanol. These results further support the hypothesis that PA and DGs formed via PLD activity function as second messengers for the induction of PLA # activity but could also reflect a non-specific effect of ethanol on PMN metabolism.
AA release and PAF formation in permeabilized human PMNs
To continue the investigation of the interrelationship between PLD activity and induction of PLA # activation, PMNs permeabilized with S. aureus α-toxin were used. Previous work in this system demonstrated that AA was specifically and maximally released when a combination of 500 nM Ca# + , a guanine nucleotide and FMLP were added to permeabilized PMNs, that radiolabelled AA release paralleled AA mass accumulation, that ATP was required for optimum enzyme activation, that inhibition of phosphorylation with staurosporine decreased the accumulation of free AA, and that the reducing agent dithiothreitol did not abolish AA release [16] . These results were most consistent with cPLA # being responsible for AA release in permeabilized PMNs, and further work demonstrated that sPLA # was inactive in the cytosolic buffer used for studies of permeabilized cells [16] . Studies also investigated whether LTB % and PAF formation could occur in the permeabilized PMN system and demonstrated that the production of both lipid mediators occurred in parallel with the activation of cPLA # [17] . Results from those investigations are summarized in Table 2 .
PA and DG production in permeabilized human PMNs
Studies were next focused on determining the effects of Ca# + , guanine nucleotides and FMLP on PA and DG formation in the permeabilized PMN model (Table 3) . Previous work demonstrated that mass release of PA in permeabilized PMNs was closely correlated with the formation of radiolabelled PA [11] , so the formation of tritiated PA and DGs was monitored in this study. As with AA release and PAF formation, stimulation of permeabilized PMNs with FMLP or the addition of 500 nM Ca# + (to mimic intracellular Ca# + concentrations attained after PMN stimulation) did not induce any changes in PA or DGs (either alkylacylglycerol or diacylglycerol) from control values. The addition of GTP[S] to induce the activation of guanine nucleotide-dependent protein (G-protein) did initiate PA formation but did not significantly increase DG production. A combination of GTP [S] and Ca# + induced the further formation of PA and initiated DG production ; stimulation with FMLP had no further effects.
GTP[S] is resistant to hydrolysis and holds G-proteins in the ' on ' conformation ; it is frequently used in signal transduction studies to enhance enzymic activity. However, under physiological conditions, G-protein activation is transient and GTP is hydrolysed to return G-proteins to the inactive, GDP-bound form. To ensure that PLD activation observed in permeabilized PMNs was not an artifact caused by the use of GTP[S], the natural guanine nucleotide was also used. GTP did not directly initiate PA or DG accumulation in permeabilized PMNs but the addition of Ca# + with GTP did increase PA levels, and stimulation with FMLP further enhanced PA accumulation and initiated the formation of both alkylacylglycerol and diacylglycerol. Thus, although the correlation of PA and DG formation (Table 3) with AA release and PAF production ( Table 2) was not perfect, PA formation was present in all cases where cPLA # activity occurred, and conditions that induced maximum AA release and PAF production also initiated DG formation.
Time course of AA release, PAF formation and PA and DG accumulation in permeabilized human PMNs
For PA and DGs to function as second messengers in the induction of cPLA # activity in PMNs requires that their production precedes or coincides with the release of AA and the formation of PAF. In control cells, no changes were evident in PA ( Figure 3A) , DG ( Figure 3B ), AA ( Figure 3C ) or PAF ( Figure 3D ) levels at any time after stimulation. When cells were treated with 500 nM Ca# + , 1 µM FMLP and either 10 µM GTP [S] or 100 µM GTP, PA production and DG formation (diacylglycerol and alkylacylglycerol formation followed a similar time course ; results not shown) were slightly increased by 0.5-1 min after cell stimulation. Under the same conditions, AA release and metabolism were also slightly increased by 1 min, whereas PAF formation was delayed but significantly different from control by 2 min. At 5 min after stimulation, PA and PAF formation, and AA release and metabolism, had reached near-maximal levels, whereas DG production continued to increase throughout the 10 min time course. Thus PA and DG formation either coincided with or preceded significant cPLA # activation.
Effects of ethanol on PA and DG formation in permeabilized human PMNs
To determine whether PA and DG formation in permeabilized PMNs was the result of PLD activation, the effects of ethanol on PA and DG formation were assessed. In the absence of stimulation, increasing ethanol levels from 0 % to 5 % had no effect on basal levels of PA ( Figure 4A ), Pet ( Figure 4B ) or alkylacylglycerol ( Figure 4C ), but did slightly decrease diacylglycerol levels ( Figure 4D ). Increasing ethanol concentrations from 0 % to 5 % induced a dose-dependent decrease in both PA and DG formation in cells stimulated with 10 µM GTP[S], 500 nM Ca# + and 1 µM FMLP (60 % decrease in PA, 80 % inhibition of alkylacylglycerol formation and 55 % lowering of diacylglycerol concentration at 2 % ethanol). The decrease in PA and DG formation in cells stimulated with GTP, Ca# + and FMLP was even more pronounced (85 %, 95% and 85 % decreases in PA, alkylacylglycerol and diacylglycerol respectively with 2 % ethanol). In concert with decreased PA and DG formation, a concomitant increase in Pet production occurred between 0 % and 2 % ethanol. These results demonstrate that the majority of PA and DGs produced in the permeabilized PMNs under conditions optimal for cPLA # activation were the result of PLD activation.
Effects of ethanol on AA release and PAF formation in permeabilized human PMNs
To determine whether blocking PLD-mediated PA and DG formation would effect AA release and metabolism and PAF formation, permeabilized PMNs were treated with increasing concentrations of ethanol immediately before the addition of Ca# + , guanine nucleotides and FMLP. Ethanol had no effect on baseline levels of free AA and metabolites ( Figure 5A 
PA and DG induction of cPLA 2 activity in permeabilized human PMNs
To explore more fully the PLD mediation of cPLA # activation, PA and DGs were added to permeabilized PMNs where endogenous PA and DG formation were decreased by ethanol pretreatment, and the effects on AA release and metabolism and PAF production were monitored. Levels of PA and DGs (0 to 10 µg per 5i10' PMNs) used for these experiments were within the physiologically relevant range on the basis of stimulated PA and DG mass production in intact PMNs [9] and PA mass measurements in permeabilized PMNs, where basal values of PA in unstimulated cells were 0.53p0.1 µg per 10( cells and increased to 1.45p0.2 µg per 10( PMNs after stimulation (results not shown).
Adding increasing concentrations of PA ( Figure 6 , filled symbols) to permeabilized PMNs had no significant effect on levels of free AA and metabolites ( Figure 6A In resting permeabilized PMNs, DGs had no significant effect on AA release and metabolism until a concentration of 10 µg of DGs was added ( Figure 6C) , and had no effect on PAF formation ( Figure 6D) . In stimulated cells, the lowest concentration of DGs (0.5 µg\ml) increased AA release, with no further enhancement occurring with higher DG concentrations. DG addition also induced an increase in PAF formation in stimulated cells : maximum PAF generation was induced with 2 µg of DGs. DGs were not as effective as PA in reconstituting cPLA # activity, with 36 % restoration of AA release and 17 % of PAF production in GTP[S]-treated PMNs (at 2 µg of DGs) and 47 % of AA and 49 % of PAF in GTP-stimulated cells. Thus both PA and DGs were able to partly reconstitute AA release and PAF formation when endogenous PA and DG formation was blocked in permeabilized PMNs, lending further support to the hypothesis that products of PLD activation participate in the induction of cPLA # activity. Because neither PA nor DGs were able to restore fully the release and metabolism of AA or the production of PAF individually, the effects of adding both lipids simultaneously were monitored. The results indicate that whereas adding the combination of 2 µg\ml PA and 2 µg\ml DGs had no effects on basal AA ( Figure 7A ) or PAF ( Figure 7B ) levels in control cells, they had additive effects on cPLA # activity, with the combination fully reconstituting AA release and PAF production in cells stimulated with either GTP [S] or GTP in combination with Ca# + and FMLP. These results suggest that the PLD-mediated production of both PA and DGs is necessary for full activation of cPLA # to occur.
DISCUSSION
Significant progress has been made in understanding the steps involved in the activation of cPLA # in PMNs and other cell types. Translocation of cPLA # from the cytosol to cell membranes [24] [25] [26] and phosphorylation of cPLA # leading to enhanced enzymic activity [27] [28] [29] [30] have been proposed as major mechanisms controlling enzyme activity, but many questions remain unanswered. For example, whereas only nanomolar concentrations of Ca# + are necessary for the translocation of cPLA # from cytosol to membrane [24] [25] [26] and these concentrations can be achieved by many agonists that interact with membrane receptors on PMNs [31] , direct stimulation of PMNs by agonists such as FMLP or complement component C5a lead to only limited AA release, or LTB % or PAF production [19] [20] [21] 32, 33] . Stimulation of PMNs with FMLP readily induces the phosphorylation of cPLA # (D. Bass, personal communication) but causes little AA release in intact PMNs. Activation of protein kinase C (PKC) has been implicated in the phosphorylation of cPLA # [28, 34, 35] but direct activation of this kinase by phorbol 12-myristate 13-acetate (PMA) or cell-permeant DGs initiates little AA release [4, 19, 21, 36] . Further, although the activation of the mitogen-activated protein kinase (MAP kinase) cascade, of Raf, and initiation of Ras activity have all been linked to cPLA # activity, the mechanism(s) coupling cell stimulation to their activation have not been elucidated [37, 38] .
In this paper we advance the hypothesis that products of PLD activation participate in the signal transduction pathway linking cell stimulation to PLA # activation. Several previous reports have suggested that a link exists between PA production and PLA # activation. PLD-mediated formation of PA can be substantially reduced via a transphosphatidylation reaction in the presence of a primary alcohol [23] , and ethanol has been shown to decrease platelet AA release and metabolism in response to stimulation (reviewed in [39] ). Further work demonstrated that ethanol treatment of platelets decreased the release of sPLA # and other granule constituents from cells after stimulation with thrombin, but had no direct effect on sPLA # enzymic activity [40] . In contrast, ethanol treatment significantly blocked cPLA # activity when the platelet enzyme was isolated and activity was measured against phospholipid vesicles. In peritoneal macrophage, ethanol treatment decreased AA release and metabolism in response to zymosan stimulation but not Ca# + ionophoreinduced AA release [41] . These results suggested that ethanol was affecting a step in the signal transduction path leading to PLA # activation and were supported by findings that ethanol abolished AA release in response to the direct activation of G-proteins by fluoroaluminate. Although activation of PLD was not addressed in those studies, the results could be consistent with effects induced by ethanol blocking the PLD-mediated formation of PA. PA facilitates the degranulation of several cell types including platelets [42] ; blocking PA accumulation via a transphosphatidylation reaction could reduce platelet degranulation [42] and thus inhibit sPLA # release. Physiological PLD activation is dependent on G-protein activity (reviewed in [6] ) ; the effects of ethanol on G-protein-induced AA release in macrophages could result from an ethanol-mediated decrease in PA formation.
Further support for a role for endogenous PA production in the induction of PLA # activity was obtained in a study where membranes isolated from PMA-pretreated platelets were stimulated with GTP[S] in the presence of 50 µM Ca# + [43] . PA production occurred in parallel with AA release in response to varying concentrations of PMA and guanine nucleotides ; PA formation preceded AA release ; and ethanol inhibited PA generation and AA release in parallel. In another report, addition of PA to phospholipid vesicles enhanced the activity of an AAspecific PLA # isolated from macrophages [44] . Suggestions that DGs function in inducing PLA # activity have also come from several sources. Cell-permeant DGs do not directly activate PLA # but enhance enzyme activity if cells are subsequently stimulated [19, 21, 36] . Diacylglycerols are the physiological activators of PKC (reviewed in [45] ), and although direct activation of PKC with PMA initiates little PLA # activity in PMNs [4, 46] it does prime cells for enhanced enzymic activity on further stimulation [35, 36, 46] . Alternatively, DGs might influence PLA # in a PKC-independent manner. Both the diacylglycerol, 1-oleoyl-2-acetylglycerol, and its alkylacylglycerol analogue, 1-O-octadecenyl-2-acetylglycerol, primed PLA # activity in PMNs for subsequent activation by FMLP or Ca# + ionophores [19, 21] ; however, whereas OAG directly activates PKC (reviewed in [47] ), most reports indicate that alkylacylglycerols do not activate PKC activation and may inhibit it [48, 49] .
In this study we first demonstrated that in intact PMNs primed
Figure 7 Combined effects of PA and DGs on AA release and metabolism and PAF production in permeabilized PMNs
Commercially prepared PA and DGs were resuspended in 100 % ethanol (EtOH) to yield final concentrations of 2 µg/ml (final ethanol concentration 2 %). PMNs (final concentration 5i10 with TNFα before stimulation with FMLP, enhanced PA and DG formation was correlated with increased AA release and PAF production. Further work showed that blocking PA and DG formation during primed stimulation led to parallel decreases in the release and metabolism of AA and formation of PAF. Studies in permeabilized PMNs, a system where cPLA # is specifically activated in the absence of sPLA # activity [16] , demonstrated that PA formation was always present when cPLA # activity occurred and that both PA and DG production were detected under conditions that maximized AA release and PAF formation. PA and DG formation preceded or coincided with cPLA # activation ; blocking endogenous PA and DG formation in the permeabilized PMN system led to a concomitant decrease in AA release and PAF production. In PMNs where endogenous PA and DG formation were prevented by ethanol pretreatment, neither PA nor DGs caused direct activation of cPLA # in control (unstimulated) cells, but adding either PA or DGs (at physiologically relevant concentrations) back to permeabilized PMNs stimulated with a guanine nucleotide, Ca# + and FMLP resulted in a partial, dose-dependent, restoration of both AA release and metabolism and PAF formation. In addition, adding a combination of PA and DGs fully reconstituted cPLA # activity in stimulated cells. These results strongly support the hypothesis that the products of PLD activation function in the signal pathway leading to the activation of cPLA # . PLA # activation could be influenced by PA at several points in the signal transduction path. PKC has been implicated in the phosphorylation of cPLA # [28, 34, 35] and in the activation of several components of the MAP kinase cascade [30, 50] and of Raf [51] ; a number of studies have shown that PA can activate PKC [52] [53] [54] [55] . PA also has been shown to stimulate MAP kinase activity directly [56] and to participate in the translocation and activation of Raf [57] . Thus PA might influence cPLA # activation by inducing the phosphorylation of one or more of the proteins involved in the signal transduction path. Alternatively, PA could affect cPLA # activity by inducing the activation of the lowmolecular-mass GTPase, Ras. In studies on the interaction of GTPase-activating proteins and GTPase-inhibiting proteins with Ras in cell-free systems, it was shown that PA inhibited GTPaseactivating protein activity and increased GTPase-inhibiting protein activity, leading to prolongation of Ras activation [58, 59] . Another point where PA might affect cPLA # is at cellular membranes. Adding PA or other anionic phospholipids to substrate vesicles led to increased AA release upon addition of an AA-specific PLA # and decreased the Ca# + requirement for PLA # activation, suggesting that the physical structure of the membrane affects PLA # activity [44] . Increased access of PLA # to substrates was also proposed as the mechanism to account for the initiation by PA of AA release in platelets [60, 61] . Thus multiple roles for PA in the induction of cPLA # can be envisaged. DGs might influence cPLA # activity by inducing PKC activation ; PKC-mediated phosphorylation has been implicated in the activation of several proteins in the path leading to cPLA # activation [28, 30, 34, 35, 50, 51] . Alternatively, a potential role for PKC-independent modulation of PLA # by DGs might involve the regulation of GTP binding to low-molecular-mass GTPases. In a study of NADPH oxidase activation in a cell-free system, both endogenously produced DGs and DGs added to membrane preparations were shown to enhance the translocation of oxidase components to cellular membranes in a GTP[S]-dependent manner [62] and it was demonstrated that DGs were influencing GTP[S] uptake by a GTP-binding protein. DGs might also influence PLA # activity by affecting the structure of cellular membranes, allowing an increased access of PLA # to substrates [63] . Whether one of these mechanisms or an alternative path could account for DG induction of cPLA # activity in permeabilized PMNs is currently under investigation.
Although PA and DG formation were required for full cPLA # activation in the permeabilized PMN system, they were not sufficient to induce AA release or PAF formation directly in the absence of cell stimulation (Figure 7) . cPLA # activity is dependent on translocation of the enzyme from the cytosol to cellular membranes, and Ca# + is required for enzyme movement [24] [25] [26] . The inability of PA and DGs to initiate cPLA # activity directly might be due to a lack of translocation of the enzyme to its substrate in cell membranes. Conversely, the near-total inhibition of PA and DG production did not completely eliminate PLA # activity in either intact or permeabilized stimulated PMNs (Figures 2 and 5) . The incomplete inhibition of AA release and PAF production by ethanol in permeabilized PMNs might result from effects of Ca# + on cPLA # translocation. In stimulated permeabilized PMNs, Ca# + is held constant at 500 nM, a level sufficient to induce the translocation of cPLA # . Phosphorylation of cPLA # is necessary for full enzymic activity [27] [28] [29] [30] but nonphosphorylated cPLA # can still cleave phospholipids [64] . If PA and DGs affect cPLA # activity by inducing phosphorylation of the enzyme, then translocation of non-phosphorylated enzyme in ethanol-treated PMNs could result in a decrease in cPLA #
